Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Aug 12;16(1):186.
doi: 10.1186/s12920-023-01622-8.

Brazilian XP-E siblings carrying a novel DDB2 variant developed early-onset melanoma: a case report

Affiliations
Case Reports

Brazilian XP-E siblings carrying a novel DDB2 variant developed early-onset melanoma: a case report

Ana Rafaela de Souza Timoteo et al. BMC Med Genomics. .

Abstract

Background: Xeroderma pigmentosum group E (XP-E) is one of the least common forms of XP, a rare syndrome where patients are prone to develop skin cancer in exposed sunlight areas. XP-E patients are generally not diagnosed until they are adults due to the mild phenotype.

Case presentation: two XP-E siblings, female, 23 years, and male, 25 years, from a Brazilian consanguineous family carrying the novel missense pathogenic variant in DDB2 gene, NM_000107.3:c.1027G > C, associated with skin cancer early-onset and severe phenotype, as nodular melanoma in the cornea and in the ear.

Conclusion: The assessment of genomic variant pathogenicity was a challenge since this family belongs to an underrepresented population in genomic databases. Given the scarcity of literature documenting XP-E cases and the challenges encountered in achieving an early diagnosis, this report emphasizes the imperative of sun protection measures in XP-E patients. Additionally, it highlights the detrimental impact of the COVID-19 pandemic on cancer diagnosis, leading to the manifestation of a severe phenotype in affected individuals.

Keywords: Case Report; Melanoma; XP-E; Xeroderma Pigmentosum.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
A Pedigree of the family showing consanguineous marriage. Both parents (I.1 and I.2) are heterozygous for NM_000107.3:c.1027G > C and patient ID_4.19 (II.4) and patient ID_4.20 (II.3) are homozygous for this variant. The two older siblings are asymptomatic and were not tested. B Reverse sequence electropherogram from mother and father of siblings. The NM_000107.3:c.1027G > C variant is highlighted in red. C Reverse sequence electropherogram from ID_4.19 and ID_4.20. D Photos to evidence severe phenotype. Patient ID_4.19 1. Photo from exeresis to remove lesions in lips, face and nose. 2 and 3. Photo of the nodular, pigmented and elevated lesion of the LE, extending throughout the cornea. 4. Photo showing the melanoma of the RE. Patient ID_4.20 5. Photo showing lesions that were removed and pigmentation on the back, exposed to sunlight. 6. Photo from exeresis of the lesion located in the right parotid gland, before surgery and 7. After the total parotidectomy. E Milestones of patient’s clinical history, Patient ID_4.19 is highlighted in blue and for Patient ID_4.20, in orange, unfortunately, he passed away on 12/06/2022
Fig. 2
Fig. 2
Genetic analysis of the WES. A XP-E patients ROH regions detected at each chromosome. The regions highlighted in blue and in red refer to ROH in Patient ID_4.20 and Patient ID_4.19, respectively. B DDB2 gene schematic representation and pathogenic variants and VUS described in databases. The exons are in yellow, all variants submitted at ClinVar and described in literature are listed (reviewed by Yang and coworkers, 2020 [26] and the variant detected in the two siblings is highlighted in red

References

    1. Kraemer KH, Digiovanna JJ. Forty years of research on xeroderma pigmentosum at the US National Institutes of Health. Photochem Photobiol. 2015;91(2):452–9. doi: 10.1111/php.12345. - DOI - PMC - PubMed
    1. Moriwaki S, Kanda F, Hayashi M, Yamashita D, Sakai Y, Nishigori C. Xeroderma pigmentosum clinical practice guidelines. J Dermatol. 2017;44(10):1087–96. doi: 10.1111/1346-8138.13907. - DOI - PubMed
    1. Masutani C, Kusumoto R, Yamada A, Dohmae N, Yokoi M, Yuasa M, et al. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta [see comments] Nature. 1999;399:700–4. doi: 10.1038/21447. - DOI - PubMed
    1. Scrima A, Koníčková R, Czyzewski BK, Kawasaki Y, Jeffrey PD, Groisman R, et al. Structural basis of UV DNA-Damage recognition by the DDB1-DDB2 complex. Cell. 2008;135(7):1213–23. doi: 10.1016/j.cell.2008.10.045. - DOI - PMC - PubMed
    1. Oh KS, Emmert S, Tamura D, Digiovanna JJ, Kraemer KH. Multiple skin cancers in adults with mutations in the XP-E (DDB2) DNA repair gene. J Invest Dermatol. 2011;131(3):785–8. doi: 10.1038/jid.2010.352. - DOI - PMC - PubMed

Publication types

Supplementary concepts

LinkOut - more resources